Labshake search

1 - 12 of 12 citations for trans Cotinine amide since 2020

• Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosis

  Lydia M. Castelli, et al., bioRxiv - Systems Biology 2021

  Quote: ... All-Trans Retinoic Acid 0.1 µM (RA; StemCell Technologies) and Purmorphamine 0.5 µM (PMN ...
• A single-cell map of hypertension

  Qiongzi Qiu, et al., bioRxiv - Physiology 2024

  Quote: ... and 0.1 μM all-trans retinoic acid (STEMCELL Technologies). Media was substituted daily until podocyte maturation on day 12 ...
• Maturation of human cardiac organoids enables complex disease modelling and drug discovery

  Mark Pocock, et al., bioRxiv - Bioengineering 2024

  Quote: ... 0.24 mM all-trans retinoic acid (Stem Cell Technologies), 0.5 mM PD173074 (Tocris ...
• Differentiation of Peritubular Myoid-Like Cells from Human Induced Pluripotent Stem Cells

  Meghan Robinson, et al., bioRxiv - Bioengineering 2021

  Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
• Microfluidic bioprinting for the in vitro generation of novel biomimetic human testicular tissues

  Meghan Robinson, et al., bioRxiv - Bioengineering 2021

  Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).
• BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes

  Titilola D. Kalejaiye, et al., bioRxiv - Bioengineering 2021

  Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies; 72262) for 5 days ...
• Genome-wide Identification of the Genetic Basis of Amyotrophic Lateral Sclerosis

  Sai Zhang, et al., bioRxiv - Genomics 2020

  Quote: ... All-Trans Retinoic Acid 0.1 μM (RA, STEMCELL Technologies, Cat.: #72262), and Purmorphamine 0.5 μM (PMN ...
• Biofabrication of a filtration barrier by integrating electrospun membranes and flow in a glomerular co-culture

  Camilla Mussoni, et al., bioRxiv - Bioengineering 2024

  Quote: ... and 0.5 µM All-trans retinoid acid (Stem Cell Technologies, 72262). After differentiation ...
• Engineered human iPS cell models reveal altered podocytogenesis and glomerular capillary wall in CHD-associated SMAD2 mutations

  Rohan Bhattacharya, et al., bioRxiv - Bioengineering 2024

  Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies, 72262).
• A Novel Organoid Model of In Vitro Spermatogenesis Using Human Induced Pluripotent Stem Cells

  Meghan Robinson, et al., bioRxiv - Bioengineering 2021

  Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
• Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis

  Rosana-Bristena Ionescu, et al., bioRxiv - Neuroscience 2024

  Quote: ... SH-SY5Y cells were counted and seeded at a density of 10.4 × 103 cells/cm2 in differentiation media (Neurobasal medium, 2% B27 supplement, 1% GlutaMAX, and 10 μM of all-trans retinoic acid [STEMCELL Technologies]). Differentiation media was replaced every other day until day 9 post-seeding ...
• An unconventional mechanism of IL-1β secretion that requires Type I IFN in lupus monocytes

  Simone Caielli, et al., bioRxiv - Immunology 2023

  Quote: ... BLaER1 cells were trans-differentiated into Mo for 6-7 days in cRPMI medium containing 10 ng/mL of hrIL-3 (Stem Cell Technologies), 10 ng/mL hrM-CSF (Stem Cell Technologies ...